Patents by Inventor Koen ALLOSERY

Koen ALLOSERY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating RSV infections
    Patent number: 10561805
    Abstract: Methods are provided for the treatment of RSV infections in young children. More specifically, methods are provided wherein polypeptides that bind F protein of hRSV and that neutralize RSV infection are administered to the lungs of young children at specific dose regimens.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: February 18, 2020
    Assignees: ABLYNX N.V., VECTURA GMBH
    Inventors: Koen Allosery, Erik Depla, Martin Huber, Tobias Kolb, Bernhard Müllinger, Massimiliano Germani, Juliane Schick, Maria-Laura Sargentini
  • Inhalation device for use in aerosol therapy of respiratory diseases
    Patent number: 10512739
    Abstract: An inhalation device, assembly or system can include a kit and a pharmaceutical composition. The device can be adapted for administering therapeutic aerosols to pediatric patients, including neonates, infants or toddlers. The device can further include a vibrating mesh aerosol generator that can be insertable into a flow channel of the inhalation device through a lateral opening, and a valved face mask. The device can be connectable to a gas source through which a gas, such as oxygen, can be received into the flow channel at a low flow rate.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: December 24, 2019
    Assignees: VECTURA GMBH, ABLYNX N.V.
    Inventors: Koen Allosery, Martin Huber, Tobias Kolb, Bernhard Müllinger, Juliane Schick, Erik Depla
  • TREATMENT OF RSV INFECTION
    Publication number: 20190127447
    Abstract: Methods are provided for the treatment of RSV infections in young children. More specifically, methods are provided wherein polypeptides that bind F protein of h RSV and that neutralize RSV infection are administered to the lungs of young children at specific dose regimens.
    Type: Application
    Filed: May 2, 2017
    Publication date: May 2, 2019
    Applicant: Ablynx N.V.
    Inventors: Maria-Laura Sargentini-Maier, Koen Allosery, Erik Depla, Massimiliano Germani
  • INHALATION DEVICE FOR USE IN AEROSOL THERAPY OF RESPIRATORY DISEASES
    Publication number: 20170304565
    Abstract: An inhalation device, assembly or system can include a kit and a pharmaceutical composition. The device can be adapted for administering therapeutic aerosols to pediatric patients, including neonates, infants or toddlers. The device can further include a vibrating mesh aerosol generator that can be insertable into a flow channel of the inhalation device through a lateral opening, and a valved face mask. The device can be connectable to a gas source through which a gas, such as oxygen, can be received into the flow channel at a low flow rate.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 26, 2017
    Inventors: Koen ALLOSERY, Martin HUBER, Tobias KOLB, Bernhard MÜLLINGER, Juliane SCHICK, Erik DEPLA
  • METHODS OF TREATING RSV INFECTIONS
    Publication number: 20170304566
    Abstract: Methods are provided for the treatment of RSV infections in young children. More specifically, methods are provided wherein polypeptides that bind F protein of hRSV and that neutralize RSV infection are administered to the lungs of young children at specific dose regimens.
    Type: Application
    Filed: October 9, 2015
    Publication date: October 26, 2017
    Inventors: Koen ALLOSERY, Erik DEPLA, Martin HUBER, Tobias KOLB, Bernhard MÜLLINGER, Massimiliano GERMANI, Juliane SCHICK, Maria-Laura SARGENTINI